Evidence map›Paper›PMID 25775507›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc.

Xiao-Xin Sun, Xia He, Li Yin, Masayuki Komada, Rosalie C Sears, Mu-Shui Dai

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 146 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

146 citing papers in PubMed, 1 synthesis or guideline pooled it, 228 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. mBio · 2026
    Article
  9. Article
  10. Review
  11. Resveratrol targets mitochondrial USP36-SOD2 to induce autophagy-ferroptosis and inhibit gastric cancer progression.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Xiao-Xin SunDepartment of Molecular and Medical Genetics, School of Medicine, and OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239;
Xia HeDepartment of Molecular and Medical Genetics, School of Medicine, and Department of Radiation Oncology, Jiangsu Cancer Hospital, Nanjing 210000, China; and.
Li YinDepartment of Radiation Oncology, Jiangsu Cancer Hospital, Nanjing 210000, China; and.
Masayuki KomadaDepartment of Biological Sciences, Tokyo Institute of Technology, Yokohama 226-8501, Japan.
Rosalie C SearsDepartment of Molecular and Medical Genetics, School of Medicine, and OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239; daim@ohsu.edu searsr@ohsu.edu.
Mu-Shui DaiDepartment of Molecular and Medical Genetics, School of Medicine, and OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239; daim@ohsu.edu searsr@ohsu.edu.
Oregon Health & Science University · USJiangsu Cancer Hospital · CNTokyo Institute of Technology · JP

Funding

Hydroxylation regulation of c-MycR01CA186241 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Mu-Shui Dai, ROSALIE C SEARS · 2015 to 2026
$4.2M
Role of Otubain 1 in the p53 PathwayR01CA160474 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI DAI, MU-SHUI · 2012 to 2016
$1.6M
Dissection of the feedback inhibition of c-Myc by L11R00CA127134 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI DAI, MU-SHUI · 2009 to 2011
$740k
NCI NIH HHS R00 CA127134NCI NIH HHS R01 CA160474NCI NIH HHS R01 CA186241
6 · The paper itself

Abstract

c-Myc protein stability and activity are tightly regulated by the ubiquitin-proteasome system. Aberrant stabilization of c-Myc contributes to many human cancers. c-Myc is ubiquitinated by SCF(Fbw7) (a SKP1-cullin-1-F-box complex that contains the F-box and WD repeat domain-containing 7, Fbw7, as the F-box protein) and several other ubiquitin ligases, whereas it is deubiquitinated and stabilized by ubiquitin-specific protease (USP) 28. The bulk of c-Myc degradation appears to occur in the nucleolus. However, whether c-Myc is regulated by deubiquitination in the nucleolus is not known. Here, we report that the nucleolar deubiquitinating enzyme USP36 is a novel c-Myc deubiquitinase. USP36 interacts with and deubiquitinates c-Myc in cells and in vitro, leading to the stabilization of c-Myc. This USP36 regulation of c-Myc occurs in the nucleolus. Interestingly, USP36 interacts with the nucleolar Fbw7γ but not the nucleoplasmic Fbw7α. However, it abolished c-Myc degradation mediated both by Fbw7γ and by Fbw7α. Consistently, knockdown of USP36 reduces the levels of c-Myc and suppresses cell proliferation. We further show that USP36 itself is a c-Myc target gene, suggesting that USP36 and c-Myc form a positive feedback regulatory loop. High expression levels of USP36 are found in a subset of human breast and lung cancers. Altogether, these results identified USP36 as a crucial and bono fide deubiquitinating enzyme controlling c-Myc's nucleolar degradation pathway.

Indexed as

Gene Expression Regulation, NeoplasticBreast NeoplasmsCatalysisCell Cycle ProteinsCell Line, TumorCell NucleolusCell NucleusCell ProliferationF-Box ProteinsF-Box-WD Repeat-Containing Protein 7FemaleGreen Fluorescent ProteinsHeLa CellsHumansLung NeoplasmsMicroscopy, FluorescenceCell Cycle ProteinsF-Box ProteinsF-Box-WD Repeat-Containing Protein 7FBXW7 protein, humanGreen Fluorescent ProteinsProto-Oncogene Proteins c-mycUbiquitin-Protein LigasesUbiquitin ThiolesteraseUSP36 protein, humanc-MycdeubiquitinationnucleolusubiquitinationUSP36

Identifiers

PMID25775507
PMCPMC4378440
OpenAlexW1967348777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.